| Drug Type Small molecule drug | 
| Synonyms K-2000 series, KAR-2581, OS-HDI-3 | 
| Target | 
| Action inhibitors | 
| Mechanism HDAC inhibitors(Histone deacetylase inhibitors), Epigenetic drug | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhasePendingDiscovery | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Graft Rejection | Discovery | United Kingdom  | - | |
| Multiple Sclerosis | Discovery | United Kingdom  | - | |
| Neoplasms | Discovery | United Kingdom  | - | |
| Psoriasis | Discovery | United Kingdom  | - | |
| Rheumatoid Arthritis | Discovery | United Kingdom  | - | |
| Systemic Lupus Erythematosus | Discovery | United Kingdom  | - | 





